Gamida Cell wins additional EMA orphan drug designation for NiCord
Gamida Cell said today that the European Medicines Agency granted its NiCord cell graft an additional orphan drug designation as a treatment for hematopoietic stem cell transplantation, or bone marrow transplantation. The treatment is a graft derived from umbilical cord blood which has been expanded and enriched with stem and progenitor cells, according to the company. The EMA previously granted orphan drug designation to NiCord for acute myeloid leukemia. Get the full story at our sister site, Drug Delivery Business News. The post Gamida Cell wins additional EMA orphan drug designation for NiCord appeared first ...
Source: Mass Device - March 23, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Oncology Regulatory/Clearance Stem Cells Wall Street Beat Gamida Cell Source Type: news

The stem cell therapy that could reverse hearing loss
Frequency Therapeutics is betting that it can change the lives of millions of Americans with hearing loss, by triggering the body’s natural ability to heal itself. Researchers have used cells in regenerative medicine for decades – in 1931, the father of cell therapy, Paul Niehans, treated a patient with material from calf embryos. Although today’s healthcare practitioners have left bovine embryonic cells behind, procedures such as bone marrow transplants are routinely used to replenish a patient’s cells after they’ve been destroyed. When scientists first derived stem cells in 1981 – a de...
Source: Mass Device - March 23, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Stem Cells Wall Street Beat Frequency Therapeutics Source Type: news

Genetic Variations Linked to Post-Transplant Outcomes in Leukemia Patients
This video examines research that found that certain genetic variations of both leukemia patients undergoing bone marrow transplant and their unrelated donors were associated with poor outcomes. (Source: CancerNetwork)
Source: CancerNetwork - March 23, 2017 Category: Cancer & Oncology Authors: Theresa Hahn, PhD Tags: Videos Hematologic Malignancies Source Type: news

Common Cold Can Be Dangerous After Bone Marrow Transplant
Rhinovirus far more worrisome in those with weakened immune systems, researchers say Source: HealthDay Related MedlinePlus Pages: Bone Marrow Transplantation, Common Cold (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 21, 2017 Category: Consumer Health News Source Type: news

Common Cold Can Be Dangerous After Bone Marrow Transplant
TUESDAY, March 21, 2017 -- The common cold can be deadly for patients recovering from bone marrow transplants, a new study warns. After a bone marrow transplant, patients have weakened immune systems. This puts them at risk for infections that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 21, 2017 Category: Journals (General) Source Type: news

Common Cold Can Be Dangerous After Bone Marrow Transplant
Rhinovirus far more worrisome in those with weakened immune systems, researchers say (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 21, 2017 Category: Respiratory Medicine Authors: webmaster at doctorslounge.com Tags: Family Medicine, Infections, Nursing, Pulmonology, Research, Immunology, News, Source Type: news

Rare cancer sufferer Daryl Allinson saved by crowdfunders
Daryl Allinson, 13, from Frome, Somerset, was struck down with a strain of leukaemia in 2015 but went into remission thanks to a bone marrow transplant from his brother. (Source: the Mail online | Health)
Source: the Mail online | Health - March 6, 2017 Category: Consumer Health News Source Type: news

Gamida Cell touts first patient treated in Phase III NiCord trial
Gamida Cell said today that the 1st patient has been treated in the Phase III registration trial of its NiCord cell graft for patients with blood cancer. The treatment is a graft derived from umbilical cord blood which has been expanded and enriched with stem and progenitor cells, according to the company. The Jerusalem-based company’s cell graft was designed as an alternative to bone marrow transplantation for patients with blood cancer who do not have a fully matched donor. Get the full story at our sister site, Drug Delivery Business News. The post Gamida Cell touts first patient treated in Phase III NiC...
Source: Mass Device - February 28, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Food & Drug Administration (FDA) Oncology Research & Development Gamida Cell Source Type: news

Merck ’s letermovir meets primary endpoint in Phase III trial to prevent CMV infection
Healthcare firm Merck has reported positive results from the Phase III clinical trial of anti-viral drug letermovir to prevent cytomegalovirus (CMV) infection in recipients of bone marrow transplant. (Source: Drug Development Technology)
Source: Drug Development Technology - February 28, 2017 Category: Pharmaceuticals Source Type: news

Merck ’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) Infection in Bone Marrow Transplant Recipients, Highly Effective Through Week 24 Post-Transplant in Pivotal Phase 3 Study
Dateline City: KENILWORTH, N.J. Letermovir Prophylaxis Associated with Lower All-Cause Mortality Through Week 24 Post-Transplant Company Plans to Submit New Drug Applications for Letermovir in U.S. and EU in 2017KENILWORTH, N.J.--(BUSINESS WIRE)--Merck& Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, today announced results of the pivotal Phase 3 clinical study of letermovir, an investigational antiviral medicine for the prevention of clinically-significant cytomegalovirus (CMV) infection in adult (18 years and older) CMV-seropositive recipients of an allogeneic hematopo...
Source: Merck.com - Research and Development News - February 26, 2017 Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News #Merck #MRK $MRK Letermovir MSD NYSE:MRK Source Type: news

Merck drug prevents serious infection after marrow transplant: study
(Reuters) - An experimental Merck& Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said. (Source: Reuters: Health)
Source: Reuters: Health - February 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation
(European Society for Blood and Marrow Transplantation) During its 43rd Annual Meeting, the EBMT will acknowledge the work that stems from the pioneering observations made by E. Donnall Thomas, also known as the father of bone marrow transplantation. At the Opening Session, Rainer Storb from the faculty of both, the Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, will give a keynote lecture entitled, '60 years of HSCT: progress from bone marrow transplantation to the first cellular and gene therapies.' (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 23, 2017 Category: Cancer & Oncology Source Type: news

Toddler with leukaemia is saved by designer immune cells
One-year-old Layla was diagnosed when she was just 14 weeks old. Chemotherapy and bone marrow transplant failed to halt the aggressive disease. She was taken to Great Ormond Street. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2017 Category: Consumer Health News Source Type: news

A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis
A 60-year-old man with a history of coronary artery disease and JAK2 V617F –positive polycythemia vera presented to our bone marrow transplantation clinic with progressive fatigue, splenomegaly, and cytopenias. (Source: CancerNetwork)
Source: CancerNetwork - February 15, 2017 Category: Cancer & Oncology Authors: Aaron M. Goodman, MD Caitlin Costello, MD Edward D. Ball, MD Megan Rust, MD Tags: Case Studies Hematologic Malignancies Oncology Journal Source Type: news

Algorithm Predicts Severe GVHD After Bone Marrow Transplant Algorithm Predicts Severe GVHD After Bone Marrow Transplant
A blood test performed 7 days after bone marrow transplant may predict serious, life-threatening GVHD and allow early intervention.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Doctors create 'MAGIC algorithm' to predict bone marrow transplant patients' risk of dying
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers at Mount Sinai Health System have discovered a way to predict whether blood cancer patients who received a bone marrow transplant will develop graft-versus-host disease, a common and often lethal complication, according to a study published in JCI (The Journal of Clinical Investigation) Insight. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2017 Category: Cancer & Oncology Source Type: news

Sixteen aplastic anemia patients free of disease after bone marrow transplant and chemo
Physicians report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 7, 2017 Category: Science Source Type: news

16 aplastic anemia patients free of disease after bone marrow transplant and chemo
(Johns Hopkins Medicine) Physicians at the Johns Hopkins Kimmel Cancer Center report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2017 Category: Cancer & Oncology Source Type: news

Health Care Special Report: Children ’s Mercy platform targets ‘Goldilocks’ doses
For some treatments, the perfect dose is a necessity. Leukemia patients, for example, take busulfan to prepare for a bone marrow transplant. Too little, and the patient ’s body won’t accept the transplant. Too much, however, can cause irreversible liver damage. “It’s a really fine line,” said Susan Abdel-Rahman, director of the pharmacokinetic and pharmacodynamics core laboratory at Children’s Mercy. She created a platform to help determine how much i s “just right” based on a child’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 3, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

‘Turbocharged artificial intelligence’ could personalize combination therapy in pediatric leukemia
In this study, patient records were obtained on the dosing of 6-mercaptopurine and methotrexate, as well as on the corresponding  absolute neutrophil count, or levels of a subset of white blood cells called neutrophils that are vital for staving off potentially life-threatening infections. These records showed multiple instances where conventional chemotherapy doses caused deviations from acceptable neutrophil levels. Using the personalized medicine technology, individualized three-dimensional maps were generated to determine the optimal 6-mercaptopurine/methotrexate drug ratios.The team members found that their techn...
Source: UCLA Newsroom: Health Sciences - December 12, 2016 Category: Universities & Medical Training Source Type: news

Researchers discover a new gatekeeper controlling T cell release into the bloodstream
(Children's Hospital& Research Center Oakland) A team of scientists led by Julie Saba, M.D., Ph.D. at UCSF Benioff Children's Hospital Oakland, has unveiled a novel role of thymic dendritic cells, which could result in new strategies to treat conditions such as autoimmune diseases, immune deficiencies, prematurity, infections, cancer, and the loss of immunity after bone marrow transplantation. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 6, 2016 Category: Infectious Diseases Source Type: news

Palliative care improves quality of life in cancer patients
Patients who received palliative care during a bone marrow transplant reported a better quality of life and reduced symptoms during hospitalization. (Source: NIH Research Matters)
Source: NIH Research Matters - December 5, 2016 Category: Research Source Type: news

Genetic factors control regenerative properties of blood-forming stem cells, UCLA studies show
FINDINGSResearchers from the UCLA Department of Medicine, Division of Hematology Oncology and the  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have published two studies that define how key genetic factors affect blood-forming stem cells by either accelerating or hindering the cells ’ regenerative properties. The findings could one day lead to improved treatments for people undergoing common therapies for cancer such as chemotherapy and radiation. BACKGROUNDBlood-forming stem cells, or hematopoietic stem cells, are found in the bone marrow. These cells have two unique...
Source: UCLA Newsroom: Health Sciences - December 5, 2016 Category: Universities & Medical Training Source Type: news

Penn study: Preventative antibiotics could prevent C. diff in transplant patients
(University of Pennsylvania School of Medicine) It may be possible to safely prevent one of the most common -- and costly to treat -- infections contracted by hospitalized patients undergoing bone marrow transplantation for the treatment of blood cancers, according to a study from the Abramson Cancer Center at the University of Pennsylvania. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2016 Category: Cancer & Oncology Source Type: news

Giving thanks: Stories of volunteerism, gratitude and giving back
Thanksgiving Day is a time rich in family, gratitude and appreciation. In honor of the holiday, we are celebrating the patient families who have traveled through our doors and the selfless acts of kindness and volunteerism that follow. Donating platelets and cycling for a cause Ten years ago, Adam Nussenbaum’s son Max was treated at Boston Children’s and overcame a life threatening illness. Today, Adam gives his time — and platelets — to help those in need, and he is doing so in celebration of Max; his daughter Kate, who donated her bone marrow to he...
Source: Thrive, Children's Hospital Boston - November 24, 2016 Category: Pediatrics Authors: Maureen McCarthy Tags: Our Patients’ Stories bone marrow transplant cerebral palsy Dr. James Kasser Family Advisory Council Heart Center Kawasaki disease Learning disabilities NICU patient partner platelet donation scoliosis Source Type: news

Palliative care helpful for cancer patients receiving bone marrow transplants
(Massachusetts General Hospital) Integrating palliative care into the treatment of patients undergoing hematopoietic stem cell transplantation - commonly known as bone marrow transplantation -- for cancers like leukemia and lymphoma can improve their quality of life, relieve symptoms associated with the procedure, and reduce depression and anxiety. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 22, 2016 Category: Global & Universal Source Type: news

Atlas, Third Rock launch new Cambridge biotech with $49M round
Atlas Venture and Third Rock Ventures have teamed up with a former GlaxoSmithKline executive to launch a new Cambridge biotech focused on improving bone marrow transplants, unveiling a $48.5 million round of financing on Wednesday. The 20-person company, Magenta Therapeutics, will be led by Jason Gardner, the former head of GSK’s research and development satellite facility in Boston. The firm is currently working out of lab space at the Forsyth Institute in Kendall Square, but plans to migrate… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 16, 2016 Category: Biotechnology Authors: Max Stendahl Source Type: news

7-Year-Old Battling Cancer Asks For The World One Simple Thing
Ava Bright Lee was diagnosed with biphenotypic leukemia in February 2014 at the age of 5. After receiving chemotherapy, radiation and a bone marrow transplant, Ava went into remission. But in October 2015, she relapsed with leukemia cutis, which caused tumors throughout her body. Doctors told her family she had three to 12 months to live. Now one year later, 7-year-old Ava is fighting for her life and asking the world for one simple thing: prayers.  On Wednesday, Ava’s family shared a heartbreaking video of the little girl making her plea for prayers in the hopes that her forthcoming PET scan would com...
Source: Healthy Living - The Huffington Post - November 4, 2016 Category: Consumer Health News Source Type: news

Girl runs into the arms of a German who saved her life after donating bone marrow
India Jaz White, from Wales, needed a bone marrow transplant to keep her alive. Her parents spent months searching for a donor before finding a 100 per cent match in Sindy, 34, from Germany. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2016 Category: Consumer Health News Source Type: news

Why Kim Kardashian West Wants You To Become A Bone Marrow Donor
Kim Kardashian West is using her huge social media platform to do some public good. This week, she’s calling attention to a major public health problem: the urgent need for people to sign up as bone marrow donors. On Monday, she posted on Facebook about 31-year-old Adam Krief, an LA-based father of three who has been diagnosed with an aggressive form of blood cancer. As West explains in her post, the cancer, known as primary myelofibrosis, can be treated with a bone marrow transplant. Finding a bone marrow donor could help Krief survive, but unfortunately, he wasn’t able to find a match in the ex...
Source: Healthy Living - The Huffington Post - September 28, 2016 Category: Consumer Health News Source Type: news

Cord-Blood Transplants Show Promise in Leukemia Treatment
Donors and recipients don't need to be a perfect match, researcher says Source: HealthDay Related MedlinePlus Pages: Bone Marrow Transplantation, Leukemia, Stem Cells (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 7, 2016 Category: Consumer Health News Source Type: news

The dark side of ‘ compassionate use ’ of experimental drugs
This is a picture of Josh Hardy. You might recall seeing his face on TV or on the #savejosh hashtag on Twitter a few years back. Josh, who was 7 at the time, had undergone a bone-marrow transplant for kidney cancer that left him hospitalized with a severe infection. He was dying. There was an experimental drug called brincidofovir made […]Related:New virtual reality fitness apps aim to make exercise less tediousHormone therapy for prostate cancer may pose a risk for black menThe added cost of eating red meat — a quicker death, scientists say (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 31, 2016 Category: Consumer Health News Source Type: news

Saving six: Life before and after transplant
An organ transplant is a life-changing event extending far beyond the operating room, the clinics and the hospital walls. Read about five children, one young adult and their families, whose lives were forever changed by the Pediatric Transplant Center at Boston Children’s Hospital. Lydia’s liver transplant, a mom’s gift Dawn Cavanagh gave her daughter life twice — first when she was born and, again, when she gave 13-year-old Lydia a piece of her liver last summer. The donor-approval process, which occurs with Boston Children’s partner Lahey Hospital & Medical Center, required hours o...
Source: Thrive, Children's Hospital Boston - August 31, 2016 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories double lung transplant ECMO heart failure heart transplant Heart transplant program heart-lung transplant Heung Bae Kim Intestine and Multivisceral Transplant Program Khashayar Vakili kidney transplant Kidney Source Type: news

Researchers identify possible pathway to reboot immune system after bone-marrow transplants
New research has shown how a cell surface molecule, Lymphotoxin ? receptor, controls entry of T-cells into the thymus, and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 25, 2016 Category: Science Source Type: news

Researchers identify possible pathway to reboot immune system after bone-marrow transplant
(University of Birmingham) New research has shown how a cell surface molecule, Lymphotoxinβ receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 25, 2016 Category: Biology Source Type: news

Bone marrow transplant patients report better quality of life compared to peripheral blood transplant recipients from unrelated volunteer donors
A large, nationwide study finds better psychological well-being, fewer graft vs. host disease symptoms and greater likelihood of returning to work among bone marrow transplant recipients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 16, 2016 Category: Science Source Type: news

Bone marrow-derived stem cells offer blood transplant patients better quality of life
(Fred Hutchinson Cancer Research Center) Large, nationwide study finds better psychological well-being, fewer graft-vs.-host disease symptoms and greater likelihood of returning to work among bone marrow transplant recipients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 16, 2016 Category: Global & Universal Source Type: news

Researchers develop new strategy to limit side effects of stem cell transplants
A new approach that may prevent leukemia and lymphoma patients from developing graft-versus-host disease (GvHD) after therapeutic bone marrow transplants has now been developed by scientists. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 15, 2016 Category: Science Source Type: news

Researchers develop new strategy to limit side effects of stem cell transplants
(Rockefeller University Press) Scientists in Germany have developed a new approach that may prevent leukemia and lymphoma patients from developing graft-versus-host disease (GvHD) after therapeutic bone marrow transplants. The researchers describe the successful application of their strategy in mice in 'Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion,' which will be published online Aug. 15 ahead of issue in the Journal of Experimental Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 15, 2016 Category: Cancer & Oncology Source Type: news

Safer bone marrow transplants 'could revolutionise arthritis treatment'
Scientists have found a way of making bone marrow transplants much safer - a development that could have far-reaching consequences for the treatment ofarthritis and many other diseases. The research from the Stanford University School of Medicine in the US remains in its early stages, but could potentially accelerate progress towards curing a wide range of chronic conditions. A new frontier for blood stem cell transplantation Bone marrow transplantation is also known as blood stem cell transplantation and can be a powerful tool in providing a longer-term solution for various conditions. However, to successfully transplant ...
Source: Arthritis Research UK - August 15, 2016 Category: Rheumatology Source Type: news

Tufts Medical Center researchers find new functions of blood cell protein in transplant
(Tufts Medical Center) Tufts Medical Center and Tufts University scientists have found exciting, new functions of the protein angiogenin that play a significant role in the regulation of blood cell formation, important in bone marrow transplantation and recovery from radiation-induced bone marrow failure. Since current bone marrow transplantations have significant limitations, these discoveries may lead to important therapeutic interventions to help improve the effectiveness of these treatments. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 11, 2016 Category: Global & Universal Source Type: news

Scientists create single treatment that could provide life-long cure for a host of diseases
Stanford University scientists have found a way of making life-saving bone marrow transplants safe. Currently the dire side effects mean they are only given to the most ill patients. (Source: the Mail online | Health)
Source: the Mail online | Health - August 11, 2016 Category: Consumer Health News Source Type: news

New method for bone marrow transplants without using chemotherapy
Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects. The new procedure could clear the way for patients to receive blood stem cells from donors more safely. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 11, 2016 Category: Science Source Type: news

Phony Cancer Treatments Still Around in Our Electronic Age
Last week in Virginia, a man was arrested on charges of posing as a doctor and prescribing phony cancer medication. The arrest is not an isolated incident. Last year, a Northern California man was arrested on charges of practicing medicine without a license and prescribing patients "natural" cures that investigators say included bags of dirt. In 2013, an evangelical minister was sentenced to 14 years in prison for pushing phony herbal supplements on parishioners dying of cancer. Experts testified that the supplements actually contained sunscreen preservative and beef flavoring. Then there's the strange case o...
Source: Healthy Living - The Huffington Post - August 10, 2016 Category: Consumer Health News Source Type: news

Study: Cord blood better than bone marrow from a donor
Stephen Feller AURORA, Colo., July 27 (UPI) -- Although doctors prefer bone marrow transplants for leukemia patients, a new study suggests umbilical cord blood offers patients a better outcome. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 27, 2016 Category: Consumer Health News Source Type: news

Cord blood outperforms matched, unrelated donor in bone marrow transplant
A new study finds that three years post-bone marrow transplant, the incidence of severe chronic graft-versus-host disease was 44 percent in patients who had received transplants from matched, unrelated donors (MUD) and 8 percent in patients who had received umbilical cord blood transplants (CBT). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 27, 2016 Category: Science Source Type: news

Cord blood outperforms matched, unrelated donor in bone marrow transplant
( University of Colorado Anschutz Medical Campus ) A University of Colorado Cancer Center study finds that three years post-bone marrow transplant, the incidence of severe chronic graft-versus-host disease was 44 percent in patients who had received transplants from matched, unrelated donors (MUD) and 8 percent in patients who had received umbilical cord blood transplants (CBT). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2016 Category: Global & Universal Source Type: news

Mesenchymal Stromal Cell Infusions May Help Patients Tolerate BMTMesenchymal Stromal Cell Infusions May Help Patients Tolerate BMT
Repeated infusion of mesenchymal stromal cells (MSCs) derived from the umbilical cords of unrelated donors may give immune tolerance to patients undergoing bone marrow transplantation, according to a phase 2 trial conducted in China. Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - July 19, 2016 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Mesenchymal Stromal Cell Infusions May Help Patients Tolerate BMT Mesenchymal Stromal Cell Infusions May Help Patients Tolerate BMT
Repeated infusion of mesenchymal stromal cells (MSCs) derived from the umbilical cords of unrelated donors may give immune tolerance to patients undergoing bone marrow transplantation, according to a phase 2 trial conducted in China. Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - July 19, 2016 Category: Pathology Tags: Hematology-Oncology News Source Type: news

HIV cure study provides insight into 2008 case
In 2008, one man, Timothy Ray Brown, was cured of HIV. Also known as the "Berlin patient," Brown was considered cured of his infection after receiving two bone-marrow transplants to treat a separate disease he had been diagnosed with a few years earl... (Source: WDSU.com - Health)
Source: WDSU.com - Health - July 18, 2016 Category: Consumer Health News Source Type: news